Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Amortization of Deferred Charges: 2009-2024

Historic Amortization of Deferred Charges for Cumberland Pharmaceuticals (CPIX) over the last 16 years, with Dec 2024 value amounting to $28,313.

  • Cumberland Pharmaceuticals' Amortization of Deferred Charges fell 50.00% to $5,362 in Q3 2025 from the same period last year, while for Sep 2025 it was $25,021, marking a year-over-year increase of 7.91%. This contributed to the annual value of $28,313 for FY2024, which is 82.39% up from last year.
  • As of FY2024, Cumberland Pharmaceuticals' Amortization of Deferred Charges stood at $28,313, which was up 82.39% from $15,523 recorded in FY2023.
  • Cumberland Pharmaceuticals' 5-year Amortization of Deferred Charges high stood at $47,636 for FY2020, and its period low was $11,237 during FY2022.
  • In the last 3 years, Cumberland Pharmaceuticals' Amortization of Deferred Charges had a median value of $15,523 in 2023 and averaged $18,358.
  • In the last 5 years, Cumberland Pharmaceuticals' Amortization of Deferred Charges crashed by 67.00% in 2022 and then spiked by 82.39% in 2024.
  • Yearly analysis of 5 years shows Cumberland Pharmaceuticals' Amortization of Deferred Charges stood at $47,636 in 2020, then fell by 28.51% to $34,053 in 2021, then crashed by 67.00% to $11,237 in 2022, then spiked by 38.14% to $15,523 in 2023, then skyrocketed by 82.39% to $28,313 in 2024.